| | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $436,073 ) |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 10 | 5/30/2024 | NON-COMPETING CONTINUATION | $436,073 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2023 ( Subtotal = $396,407 ) |
| 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 008 | 9 | 6/30/2023 | NON-COMPETING CONTINUATION | $365,300 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 002 | 8 | 11/17/2022 | NON-COMPETING CONTINUATION | $474,512 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 005 | 8 | 3/22/2023 | NON-COMPETING CONTINUATION | $0 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 003 | 8 | 11/21/2022 | SUPPLEMENT FOR EXPANSION | $269,997 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 8 | 11/4/2022 | SUPPLEMENT FOR EXPANSION | -$269,997 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 8 | 11/4/2022 | NON-COMPETING CONTINUATION | -$474,512 |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 004 | 8 | 1/11/2023 | NON-COMPETING CONTINUATION | $31,107 |
| 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 006 | 6 | 5/23/2023 | COMPETING CONTINUATION | -$2,000 |
| 2023 | 2021 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 007 | 7 | 5/23/2023 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $2,000 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2022 ( Subtotal = $744,510 ) |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 012 | 8 | 9/19/2022 | SUPPLEMENT FOR EXPANSION | $269,997 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 011 | 8 | 9/13/2022 | NON-COMPETING CONTINUATION | $474,512 |
| 2022 | 2021 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 006 | 7 | 8/9/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $1 |
| 2022 | 2021 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 004 | 7 | 5/27/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $323,615 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 003 | 6 | 5/27/2022 | COMPETING CONTINUATION | -$323,614 |
| 2022 | 2021 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 008 | 7 | 8/9/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $224,821 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 007 | 6 | 8/9/2022 | COMPETING CONTINUATION | -$224,821 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 005 | 6 | 8/9/2022 | COMPETING CONTINUATION | -$1 |
| 2022 | 2021 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 009 | 7 | 8/11/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $0 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 002 | 6 | 4/6/2022 | COMPETING CONTINUATION | $324,898 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 010 | 6 | 9/13/2022 | COMPETING CONTINUATION | $0 |
| 2022 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 5 | 4/6/2022 | NON-COMPETING CONTINUATION | -$323,928 |
| 2022 | 2019 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 4 | 4/6/2022 | NON-COMPETING CONTINUATION | -$970 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2021 ( Subtotal = $323,615 ) |
| 2021 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 6 | 7/14/2021 | COMPETING CONTINUATION | $323,615 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2020 ( Subtotal = $323,928 ) |
| 2020 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 5 | 7/8/2020 | NON-COMPETING CONTINUATION | -$3,651 |
| 2020 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 002 | 5 | 7/22/2020 | NON-COMPETING CONTINUATION | -$1,768 |
| 2020 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 5 | 5/5/2020 | NON-COMPETING CONTINUATION | $329,347 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2019 ( Subtotal = $319,422 ) |
| 2019 | 2019 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 4 | 5/3/2019 | NON-COMPETING CONTINUATION | $319,422 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2018 ( Subtotal = $314,400 ) |
| 2018 | 2018 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 3 | 6/27/2018 | NON-COMPETING CONTINUATION | $314,400 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2017 ( Subtotal = $318,564 ) |
| 2017 | 2017 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 2 | 7/11/2017 | NON-COMPETING CONTINUATION | $315,972 |
| 2017 | 2017 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 1 | 4/13/2017 | SUPPLEMENT FOR EXPANSION | $2,592 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2016 ( Subtotal = $158,919 ) |
| 2016 | 2016 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE NO J6-330 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 1 | 7/27/2016 | NEW | $158,919 |
|
|